Imavita is proud to announce the acquisition of new Optical Coherence Tomography apparatus.

Since september 2017, Imavita is working on this innovative imaging system (OQ Labscope / Lumedica) which will permit to generate non-invasive, surface tissue quantitative data for pre-clinical models in place at Imavita in Applications of interest, principally in the area of dermatology.OCT preclinical model Imavita

The benefits of this in vivo imaging modality are:

  • Easily and efficiently obtain calibrated quantitative data in preclinical models
  • Deepen understanding of disease mechanisms, disease progression and therapeutic responses
  • Manage costs and capture time course data by avoiding sacrifice of animal models

For more informations, do not hesitate to contact us.

Categories: News

Gravityscan Badge